Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain
Status:
Recruiting
Trial end date:
2022-01-24
Target enrollment:
Participant gender:
Summary
This study is being done to test the safety and efficacy of the study drug LY3556050 for the
treatment of chronic low back pain. This trial is part of the chronic pain master protocol
(H0P-MC-CPMP) which is a protocol to accelerate the development of new treatments for chronic
pain.